Vanda Pharmaceuticals Inc.
MULTIPLE MYELOMA TREATMENT

Last updated:

Abstract:

The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).

Status:
Application
Type:

Utility

Filling date:

26 Aug 2019

Issue date:

9 Jan 2020